Breast Cancer Awareness Month News regarding Breast Cancer Awareness Month

Latest

Oct 09, 2019, 09:00 ET Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy

Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and...


Oct 08, 2019, 08:00 ET Health Canada Approves EVENITY® For the Treatment of Osteoporosis in Postmenopausal Women at High Risk for Fracture

MISSISSAUGA, ON, Oct. 8, 2019 /CNW/ - Today Amgen Canada announced that EVENITY® (romosozumab) is now available in Canada for the treatment of...


Oct 07, 2019, 08:00 ET United in purpose, Team CIBC raises $3 million as they walk, run, fundraise and volunteer alongside Canadians to create a future without breast cancer

15,000 team members in 57 communities rally together for another successful CIBC Run for the Cure TORONTO, Oct. 7, 2019 /CNW/ - CIBC (TSX: CM) (NYSE: ...


Oct 06, 2019, 17:50 ET Canadians raise $17 million at the Canadian Cancer Society CIBC Run for the Cure

Funds raised benefit breast cancer research and the country's largest support system for people facing breast cancer TORONTO, Oct. 6, 2019 /CNW/ -...


Oct 04, 2019, 12:03 ET ShopperArmy.ca Launches 'Shop For The Cure' in Support of Breast Cancer Awareness Month

— A first-of-its-kind fundraiser between a cash back rewards site and a Canadian charity, providing a convenient way for Canadians to donate while...


Oct 01, 2019, 16:09 ET Breast Cancer Awareness Month: Frost & Sullivan Identifies Key Benefits of Breast Ultrasound Solutions

Frost & Sullivan supports Breast Cancer Awareness Month and research with its latest analysis, Global Breast Ultrasound Market, Forecast to 2023....


Oct 01, 2019, 09:00 ET WestJet brings pink to the skies in support of a future without breast cancer

Airline has raised more than $500,000 for breast cancer research and programs since 2013 CALGARY, Oct. 1, 2019 /CNW/ - As the official airline of the ...


Sep 29, 2019, 05:58 ET Agendia Presents New Data on the Biological Characteristics of Patients within Extreme Low Risk and High Risk MammaPrint Subgroups at the European Society for Medical Oncology (ESMO)

Agendia Inc., a world leader in precision oncology for breast cancer, will present new data from their on-going clinical research at the European...


Sep 27, 2019, 13:19 ET Health Canada approves Tecentriq® in combination with chemotherapy (nab-paclitaxel) as first immunotherapy treatment for aggressive form of breast cancer(1)

New approval provides patients with PD-L1 positive, metastatic triple-negative breast cancer with an additional treatment option that significantly...


Sep 26, 2019, 11:19 ET Cashmere Collection Unites History's Legends of Fashion With 16 Top Canadian Designers to Support Breast Cancer Cause

Cashmere Collection: Legends of Fashion pays homage to icons of fashion as 16 Canadian designers showcase their Cashmere Bathroom Tissue (BT) Couture ...


Sep 26, 2019, 09:17 ET Nature Communications Publishes Studies on Medicenna's IL-2 Superkine Platform

Long-acting and Tumor Targeting MDNA109 Variants Dramatically Improve T-cell Stimulation, Tumor Control and Long Term Memory Response TORONTO, Sept....


Sep 23, 2019, 08:15 ET Menarini Silicon Biosystems to Host ESMO Symposium on Clinical Importance of Circulating Tumor Cells

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, will host a symposium on the importance of liquid biopsy and...


Sep 23, 2019, 08:00 ET ESMO Annual Meeting 2019: Menarini Ricerche Presents the Preclinical Characterization of MEN1611, a Novel PI3K Inhibitor in Development for the Treatment of Breast Cancer

Promising results from the preclinical study conducted by Menarini Ricerche on MEN1611, a potent and selective orally available phosphatidylinositol...


Sep 19, 2019, 07:00 ET Addition of KISQALI® to drug plan in Quebec expands access to treatment for metastatic breast cancer

Provincial reimbursement provides public access to treatment that may delay the progression of advanced breast cancer DORVAL, QUEBEC, September 19,...


Sep 18, 2019, 09:30 ET Densitas Inc. Wins Major Procurement of Its AI-Powered Breast Density Software for DIMASOS Breast Screening Trial

- Densitas Inc., a leading provider of AI solutions for digital mammography, announced today it has won a procurement of its densitas densityai™...


Sep 11, 2019, 10:14 ET Teva Canada Announces the Approval of HERZUMA®, a biosimilar to HERCEPTIN® for the treatment of adult patients with Early Breast Cancer, Metastatic Breast Cancer and Metastatic Gastric Cancer

This is the second Notice of Compliance (NOC) issued for a biosimilar in 2019 that Teva Canada Innovation will add to its portfolio of brands,...